Donna Wall, MD, CCPE
Dr. Wall joined SickKids/University of Toronto in the fall of 2016 as Section Head of the Blood and Marrow Transplant/Cellular Therapy program. After completing pediatric and pediatric hematology/oncology training in New York and Boston she went on to establish BMT and public cord blood banks in St. Louis and San Antonio. Most recently she has led the Manitoba Blood and Marrow Transplant program. She has chaired the hematopoietic stem cell transplant discipline in the Children’s Oncology Group and has had leadership positions in the Pediatric Blood and Marrow Transplant Group, the Canadian Blood and Marrow Transplant Group and the CIHR-funded Canadian National Transplant Research program. Her research has focused on improving the outcomes of children undergoing transplant through a better understanding of the role of the innate immune system in transplantation and the interaction between donor immune cells and their new environment as tolerance is established and as a tool to treat leukemia.
Kristjan Paulson, MD, FRCPC
Dr. Paulson is a member of the Manitoba Blood and Marrow Transplant Program, based out of CancerCare Manitoba. A life long Manitoba resident, he completed his medical school, internal medicine and hematology training at the University of Manitoba. After a brief stop in Milwaukee for additional Blood and Marrow Transplant (BMT) training, he started on staff in Winnipeg in 2013. He is the service chief of the GD6 Transplant/Oncology unit at Health Sciences Centre, and is chair of the Leukemia Disease Site Group at CancerCare Manitoba. His main area of research interest is retrospective outcomes research in BMT, and is the Scientific Director of the Canadian Blood and Marrow Transplant Group (CBMTG) Registry.
Andrew Daly, MD, FRCPC
Dr. Andrew Daly received his medical training at McGill University in Montreal. He subsequently completed post-graduate training in hematology at McGill and a fellowship in hematopoietic stem cell transplantation at the University of Toronto. He is currently the director of the Alberta Blood and Marrow Transplant Program at the University of Calgary and a clinical associate professor at the Cumming School of Medicine, University of Calgary. His research interests include expanding access to hematopoietic cell transplantation through the use of alternative donors and improving the outcome of transplantation through the use or safer preparative regimens.
Auro Viswabandya, MD, DM
Dr. Auro Viswabandya has completed his specialty training in India and then did a 3 year fellowship in "Malignant Hematology and Stem Cell Transplantation" in Princess Margaret Cancer Center. He was a staff in the largest Hematology center in India for 10 years before moving to Princess Margaret Cancer Center as an active staff in Allogeneic Stem Cell Transplant Division. Dr. Auro Viswabandya is appointed as an Assistant Professor in the Division of Medical Oncology, Department of Medicine, University of Toronto. He is currently the Associate Director and Fellowship Supervisor in the Allogeneic Stem Cell Transplant Program at PMH.
He has published more than 100 peer reviewed journal articles and 5 book chapters to his credit. His areas of interest are GVHD prophylaxis in allogeneic stem cell transplant and Haploidentical stem cell transplantation.
He specifically looks at the combination of Anti-Thymocyte Globuline (ATG) and post-transplant Post Transplant Cyclophosphamide (PTCy) in patients undergoing allogeneic stem cell transplantation.
Currently, Dr. Viswabandya is the fellowship and residents (PGY5) supervisor of allotransplant at Princess Margaret Cancer Centre. Education is his passion and he is currently the member of Education Committee of CBMTG and ASBMT. He is a member of Stem Cell Transplantation Advisory Committee of Cancer Care Ontario.
Charlene Downey, MN, NP(Adult), RN, CON (c)
Charlene Downey is a Nurse Practitioner in Hematology with Eastern Health at the Health Science Center in St. John’s, Newfoundland. Her clinical work currently focuses on malignant hematology, autologus and allogeneic stem cell transplants. Her career has seen her as a staff nurse on the Hematology/Oncology inpatient unit, clinical educator, and clinical instructor with Memorial University. Charlene completed her Bachelor of Nursing at Memorial in 1997, and her MN from Memorial in 2006 with a clinical focus, obtaining her Nurse Practitioner – Adult Acute Care credential. Charlene holds the position of a Professional Associate with Memorial University. Her areas of interested are in the treatment of Graft vs Host Disease, Cancer Survivorship, Lymphoma, and advancing nursing roles and knowledge in Hematology/Oncology. She is a member of CANO and CBMTG.
Kylie Lepic, MD, FRCPC
Dr. Kylie Lepic received her MD from McMaster University in 2006. She completed her Internal Medicine and Hematology Residency training at McMaster followed by a Fellowship in Blood and Marrow Transplant at the Fred Hutchinson Cancer Research Center in Seattle, WA. Dr. Lepic is currently an Assistant Professor in the Department of Medicine at McMaster and is based at the Juravinski Hospital and Cancer Centre. She has a special interest in histocompatibility.
Kirk Schultz, MD, FCAHS
Dr. Kirk Schultz is a Professor at the University of British Columbia, BC Children’s Hospital, and the Child and Family Research Institute (CFRI). Dr. Schultz is a Pediatric Hematologist/Oncologist focused on new therapies and rejection in Blood and Marrow Transplantation (BMT) and immune therapy of blood cancers. Dr. Schultz is a past recipient of the CIHR/Wyeth Clinical Research Chair in Transplantation, past chair of the CBMTG CTN, and past chair of the Pediatric BMT Consortium the largest children’s BMT clinical trials group in the world. Dr. Schultz is also a fellow of the Canadian Academy of Health Sciences. He is currently the director of the Michael Cuccione Childhood Cancer Research Program group at the BC Children’s Hospital and CFRI and the lead on Core 2 of the CNTRP.